PAG
ALDX icon

Private Advisor Group’s Aldeyra Therapeutics ALDX Stock Holding History

Private Advisor Group’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-49,165
Closed -$196K – 1916
2022
Q2 		$196K Buy
+49,165
New +$169K ﹤0.01% 1846
2020
Q3 		– Sell
-1,112
Closed -$5K – 1616
2020
Q2 		$5K Buy
+1,112
New +$4.06K ﹤0.01% 3211

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Private Advisor Group's ALDX Position: Q3 2022 in Review

Private Advisor Group sold out of Aldeyra Therapeutics (ALDX) in Q3 2022, closing a stake of 49,165 shares — an estimated $196K sold.

Private Advisor Group first reported a position in ALDX in Q2 2020 and held it in 2 quarters. The position peaked at $196K in Q2 2022. 89 funds tracked by Wall St. Rank hold ALDX as of Q3 2022.

  • Private Advisor Group reported no remaining Aldeyra Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Private Advisor Group sold 49,165 Aldeyra Therapeutics shares in Q3 2022, an estimated $196K.
  • Private Advisor Group first reported a position in Aldeyra Therapeutics in Q2 2020 and held it in 2 quarters.
  • Private Advisor Group's Aldeyra Therapeutics position peaked at $196K in Q2 2022.
  • 89 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2022.

Based on Private Advisor Group's 13F filing for Q3 2022, filed 14 Oct 2022.